Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear
Sensorion, a pioneering clinical-stage biotechnology company that specializes in the development of novel therapies to […]
Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors
Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure […]
Bruno Ultra Barcelos is appointed Managing Director of Ethypharm UK
The Ethypharm Group, a European pharmaceutical company focused on the Central Nervous System and Hospital […]
Vesigen Therapeutics Names Rakhshita Dhar to Board of Directors
Vesigen Therapeutics, a biotechnology company developing transformative therapeutics by engineering naturally existing vesicles, today announced […]
Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer
Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced […]
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
Immusoft of CA, a wholly owned subsidiary of Immusoft, a clinical-stage cell therapy company dedicated […]
BioSenic appoints Yves Sagot as Independent Director
BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and cell repair, today announces […]
Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors
Kinnate Biopharma, a clinical-stage precision oncology company, has announced that its board of directors has […]
Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment
Nogra Pharma, a clinical-stage biotechnology company developing innovative therapeutics for immune-inflammatory-mediated diseases, today announces it […]
Cerebral Therapeutics Names Julie Foster as Chief Operating Officer
Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment […]
- MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Read more
- Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Read more
- Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Read more
- Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Read more
- Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Read more